Stem cell registry programme for patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting: what benefits does it derive?

AIMS: Standardization of stem cell therapy requires application of appropriate methods to evaluate safety and efficacy, including long‐term pharmacovigilance. To accomplish this objective, a long‐term registry programme was installed. METHODS AND RESULTS: We analysed 150 patients with ischemic cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nesteruk, Julia, Voronina, Natalia, Kundt, Guenther, Donndorf, Peter, Klopsch, Christian, Kaminski, Alexander, Duckers, Henrick J., Steinhoff, Gustav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396044/
https://www.ncbi.nlm.nih.gov/pubmed/28451446
http://dx.doi.org/10.1002/ehf2.12132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396044/
https://www.ncbi.nlm.nih.gov/pubmed/28451446
http://dx.doi.org/10.1002/ehf2.12132

Ejemplares similares